NCT00069459 - Seasonal Affective Depression (SAD) Study | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

September 23, 2003

Primary Completion Date

June 3, 2004

Study Completion Date

June 3, 2004

Conditions

Depressive Disorder

Interventions

DRUG

Extended-release Bupropion Hydrochloride

Bupropion hydrochloride will be available in dose strength of 150 and 300 milligram (mg). Subjects will receive one tablet of 150 mg bupropion hydrochloride from Day 1 to 7, from Day 8 to Week 27 will receive one tablet of 300 mg bupropion hydrochloride and from Week 28-29 one tablet of bupropion hydrochloride

Trial Locations (48)

10021

GSK Investigational Site, New York

10032

GSK Investigational Site, New York

10128

GSK Investigational Site, New York

11559

GSK Investigational Site, Lawrence

12208

GSK Investigational Site, Albany

14618

GSK Investigational Site, Rochester

18104

GSK Investigational Site, Allentown

19083

GSK Investigational Site, Havertown

19106

GSK Investigational Site, Philadelphia

19713

GSK Investigational Site, Newark

19808

GSK Investigational Site, Wilmington

20016

GSK Investigational Site, Washington D.C.

20852

GSK Investigational Site, Rockville

21204

GSK Investigational Site, Baltimore

43210

GSK Investigational Site, Columbus

43623

GSK Investigational Site, Toledo

44124

GSK Investigational Site, Lyndhurst

45219

GSK Investigational Site, Cincinnati

48334

GSK Investigational Site, Farmington Hills

52401

GSK Investigational Site, Cedar Rapids

53051

GSK Investigational Site, Menomonee Falls

53223

GSK Investigational Site, Brown Deer

53719

GSK Investigational Site, Madison

55454

GSK Investigational Site, Minneapolis

60093

GSK Investigational Site, Northfield

60181

GSK Investigational Site, Oakbrook Terrace

60194

GSK Investigational Site, Hoffman Estates

60523

GSK Investigational Site, Oak Brook

62025

GSK Investigational Site, Edwardsville

63108

GSK Investigational Site, St Louis

66211

GSK Investigational Site, Overland Park

68198

GSK Investigational Site, Omaha

83702

GSK Investigational Site, Boise

97201

GSK Investigational Site, Portland

97209

GSK Investigational Site, Portland

97210

GSK Investigational Site, Portland

97401

GSK Investigational Site, Eugene

99204

GSK Investigational Site, Spokane

99508

GSK Investigational Site, Anchorage

06518

GSK Investigational Site, Hamden

02478

GSK Investigational Site, Belmont

07033

GSK Investigational Site, Kenilworth

08057

GSK Investigational Site, Moorestown

08854

GSK Investigational Site, Piscataway

08540

GSK Investigational Site, Princeton

02865-4208

GSK Investigational Site, Lincoln

05091

GSK Investigational Site, Woodstock

53562-2215

GSK Investigational Site, Middleton